Johnson & Johnson’s Janssen Pharmaceuticals unit was hit with a $5.6 million verdict by a California jury on October 16 over the death of Leo Liu during the company’s clinical study of Risperdal, a well-known anti-psychotic medication. The victim’s mother, Marion Liu, said that her son participated in Janssen’s human drug trial and that he died when Janssen’s employees did nothing to treat his heart condition during the drug trial.
Due to the jury’s finding that Janssen Research and Development LLC was 70% responsible for Liu’s death in the trial, the Johnson & Johnson subsidiary has been ordered to pay the $5.6 million to Liu’s family. Liu’s psychiatrist, Madeleine Valencerina, was also implemented in the trial. Valencierina allegedly received a payout from Janssen for convincing Liu to join the drug trial; she is being held liable for the remaining 30% of the settlement, bringing the total up to $8 million.
Risperdal is known to cause new or exacerbated conditions in patients who take it for anti-psychosis, and our team of lawyers at Williams Kherkher want you to know that you may be able to recover compensation for your suffering as a result of this drug. Call us today at (888) 220-0640 to learn more.
Following dozens of lawsuits alleging a link between Ethicon Inc.’s power morcellators and the spread of uterine cancer, a federal judicial panel has created a federal docket in the District of Kansas in order to consolidate these cases and accelerate the process of reaching settlements.
One example of a pending lawsuit involves a woman from Colorado who had a laparoscopic procedure in which the surgeon used a morcellator manufactured by Ethicon to treat her uterine fibroids. Soon after her procedure, she was told that one of her fibroids contained leiomyosarcoma. She has been in radiation treatment and chemotherapy, which she claimed to be disabling and painful.
The plaintiff complained that even with Ethicon’s knowledge of the new evidences and safety hazards, the manufacturer still failed to design their power morcellator product in a way that would lessen the risk of uterine cancer.
If your health has been suffering after the use of a power morcellator during your surgery, consider speaking with our legal team at Williams Kherkher to build a case against the liable party. Call us today at (888) 220-0640.
A long section of scaffolding around a seven-story building collapsed in Houston earlier today, and CNN has reported that at least six construction workers have been injured in the incident. Senior Captain Ruy Lozano of the Houston Fire Department told reporters at the scene that none of the injuries sustained in the accident were life-threatening.
Though firefighters are still searching the scene to ensure that no one else is trapped underneath the collapsed structure, Senior Capt. Lozano went on to report that there were no confirmations of missing workers. The scene appears to be stable, but the senior captain went on to warn that a secondary collapse may still be possible.
The cause of the collapse, which took place near Minute Maid Park, has not yet been determined.
According to Legal Herald, many power morcellator manufacturers are facing an increase in lawsuits after the U.S. Food and Drug Administration (FDA) announced a safety warning this past year.
Currently, there has been a count of about 30 lawsuits filed against several manufacturers including big names like Richard Wolf GmBH, Karl Storz, Ethicon, and Gyrus ACMI. It was also reported that each of these lawsuits involved a woman that had recently undergone laparoscopic surgery and was diagnosed with uterine cancer after using the morcellator. The plaintiffs had radiation treatments and chemotherapy. There have also been reported deaths among the plaintiffs, even with the treatment.
Ethicon had already announced the withdrawal of their morcellators from the market following the FDA’s safety warning. Ethicon believes that it is the best move until new medical guidelines are released.
If you think you are suffering from having used a morcellator, strengthen your case by consulting with our power morcellator lawyers at Williams Kherkher. Call us now at (888) 220-0640.
Risperdal (risperidone) is the antipsychotic medicine which functions include changes in the chemical effects in the brain. It is normally a treatment for manic depression symptoms and schizophrenia.
The common side effects of Risperdal include headache, depressed mood, weight gain, tremors, agitation, constipation, and many others. According to Drugs.com, you should be alert after taking this medicine and must immediately seek medical help once the following occurs:
- Tenderness/swelling of breasts, both in men and women; nipple discharge; missed menstruations
- Indications of high blood sugar: dry mouth, increased thirst, drowsiness, increased urination
- Painful penis erection
- Harsh nervous system reaction such as high fever, fast or uneven heartbeats and rigid muscles
- Indication of low platelet level: easy bruising, unusual bleeding of the mouth, nose, vagina, or rectum, purple or red spots under the skin
Drugs.com listed further important information about Risperdal on their website.
If you have been affected by the negligence of Risperdal manufacturers, consult with our legal team at Williams Kherkher. Call us today at (888) 220-0640.
Three people were killed and four others injured on Thursday when an explosion took place at a Williams Partners’ facility in Gibson, Louisiana, approximately 70 miles outside of New Orleans. Although the plant was not fully operational at the time of the explosion, there were several people performing maintenance work on the plant when the explosion took place.
The blast caused a subsequent fire at the plant that burned until 6 pm on Thursday. Of the four individuals injured in the blast, two remain in critical condition. Authorities have yet to determine exactly what caused this explosion and subsequent fire, but will continue to investigate the incident.
In the second industrial explosion to take place within a week in Pasadena, TX, three people were injured when an explosion and subsequent fire occurred at a chemical storage plant owned by Schultz Container Systems. The Houston Fire Department responded to the incident and two firefighters, as well as one employee of the plant, sustained injuries and were taken to the hospital.
There were approximately 30 employees cleaning containers at the plant when a “flash explosion” of some type of chemical occurred. Firefighters struggled to battle the blaze, as they were unsure of what chemicals were involved in the explosion and following fire. The condition of those injured is not known at this time, and the cause underlying cause of the explosion is still being investigated.
A Pasadena chemical plant is raising concerns after announcing it will resume operations less than a week after an explosion that left four workers with serious burns. The explosion occurred after silane gas was released from a cracked line workers were operating on. The explosion left one employee so severely burned that he is expected to have to undergo long-term care and treatment. This is not the first time that the company has had safety issues, with a history of leaks and separate 2008 incidents that sent 15 individuals to the hospital.
Many experts are saying that investigating such an incident, as well as exploring why the company has had repeat accidents, should take far longer than a week. Although the company reports that the incident was an isolated event, many are concerned that they have not discovered the root cause of the repeated accidents in such a short period of time. The Occupational Safety and Health Administration (OSHA) is still investigating the explosion, but has no authority to shut company operations down. The chemical plant has not fully elaborated on what safety measures they are putting in place to prevent a future accident.
Johnson & Johnson’s aggressive marketing of the antipsychotic medication Risperdal has caused quite a controversy, especially since they allegedly withheld data about potential side effects such as breast development and stroke.
Upon its initial release in 1994, Johnson & Johnson had a small market for Risperdal, as the Food and Drug Administration said it was not necessarily better than any previous version of antipsychotics, and was targeted specifically for those suffering from schizophrenia . J&J later overhauled Risperdal and branded it as a medicine for a wide range of medical problems. Johnson & Johnson formed ElderCare and prescribed Risperdal even when it was not approved for consumption by the elderly. FDA protested and has reported numerous deaths among the ones who took the drugs.
Johnson & Johnson has profited handsomely from these crimes. Although they were hit with $2 billion in penalties and settlements, J&J has seen $30 billion in Risperdal sales around the world. If you know someone who has been harmed by the side effects brought by Risperdal, you may want to seek legal assistance in order to recover financial compensation. Speak with our experienced legal team at Williams Kherkher by calling us today at (888) 220-0640.
An explosion on Friday at a Pasadena, TX chemical plant resulted in injuries to four workers, including one 42-year-old man who was sent via life flight to a nearby hospital to receive treatment for severe chemical burns to his chest and face.
According to authorities, the plant, which was located on the Houston ship channel, manufactures a variety of different chemicals and is owned by Albemarle Corporation. The site is operational seven days a week, and employs 300 workers on site. Authorities reported that there was no risk of chemicals harming those in the nearby community, and as of Friday afternoon, a fire that resulted from the explosion had been put out.
Investigators are still looking into the incident to determine what caused the explosion in the first place. Our team here at Williams Kherkher will continue to monitor this situation and will provide more information as it becomes available.